Human Immunodeficiency Virus and Clonal Hematopoiesis

Human Immunodeficiency Virus and Clonal Hematopoiesis

The evolution of antiretroviral therapies (ART) has tremendously improved the life expectancy of people living with human immunodeficiency virus (HIV) (PLWH), which is currently similar to the general population. However, as PLWH are now living longer, they exhibit various comorbidities such as a hi...

Full description

Bibliographic Details
Main Authors:	Stamatia C. Vorri, Ilias Christodoulou, Styliani Karanika, Theodoros Karantanos
Format:	Article
Language:	English
Published:	MDPI AG 2023-02-01
Series:	Cells
Subjects:	HIV human immunodeficiency virus clonal hematopoiesis non-AIDS related comorbidities
Online Access:	https://www.mdpi.com/2073-4409/12/5/686

Similar Items

New approaches to idiopathic neutropenia in the era of clonal hematopoiesis
by: Olisaemeka D. Ogbue, et al.
Published: (2023-04-01)

Association of Clonal Hematopoiesis of Indeterminate Potential with Inflammatory Gene Expression in Patients with COPD
by: Stefan Kuhnert, et al.
Published: (2022-07-01)

Common in atherogenesis and carcinogenesis: clonal hematopoiesis
by: A. A. Sleptsov, et al.
Published: (2023-11-01)

Cancer patients with clonal hematopoiesis die from primary malignancy or comorbidities despite higher rates of transformation to myeloid neoplasms
by: Kelly S. Chien, et al.
Published: (2024-03-01)

Evaluation of clonal hematopoiesis and mosaic loss of Y chromosome in cardiovascular risk: An analysis in prospective studies
by: Sami Fawaz, et al.
Published: (2024-12-01)

Clonal hematopoiesis and acute myeloid leukemia
by: A. I. Kashlakova, et al.
Published: (2023-09-01)

Longitudinal profiling of clonal hematopoiesis provides insight into clonal dynamics
by: Md Mesbah Uddin, et al.
Published: (2022-05-01)

Clonal hematopoiesis of indeterminate potential: clinical relevance of an incidental finding in liquid profiling
by: Hoermann Gregor
Published: (2022-08-01)

Clonal hematopoiesis of indeterminate potential and heart failure
by: E. A. Lyasnikova, et al.
Published: (2024-12-01)

Clonal hematopoiesis as a novel risk factor for type 2 diabetes mellitus in patients with hypercholesterolemia
by: Min Joo Kim, et al.
Published: (2023-06-01)

From Clonal Hematopoiesis to Therapy-Related Myeloid Neoplasms: The Silent Way of Cancer Progression
by: Carmelo Gurnari, et al.
Published: (2021-02-01)

Fatal Progression of Mutated TP53-Associated Clonal Hematopoiesis following Anti-CD19 CAR-T Cell Therapy
by: Lea Naomi Eder, et al.
Published: (2023-01-01)

Clonal hematopoiesis of indeterminate potential is associated with increased risk of immune checkpoint inhibitor myocarditis in a prospective study of a cardio-oncology cohort
by: Rachel Jaber Chehayeb, et al.
Published: (2024-11-01)

Clonal abundance patterns in hematopoiesis: Mathematical modeling and parameter estimation
by: Yunbei Pan, et al.
Published: (2023-02-01)

The Presence of Clonal Hematopoiesis Is Negatively Associated with Diabetic Peripheral Neuropathy in Type 2 Diabetes
by: Tae Jung Oh, et al.
Published: (2022-04-01)

Association Between Clonal Hematopoiesis Driver Mutations, Immune Cell Function, and the Vasculometabolic Complications of Obesity
by: Helin Tercan, et al.
Published: (2024-01-01)

Measures of Clonal Hematopoiesis: Are We Missing Something?
by: Leonid V. Bystrykh, et al.
Published: (2022-03-01)

Clonal Hematopoiesis and Liquid Biopsy in Gastrointestinal Cancers
by: Vlad M. Croitoru, et al.
Published: (2022-01-01)

Cutaneous Langerhans cell histiocytosis and other systemic inflammatory or autoimmune disease manifestations in the setting of clonal hematopoiesis
by: Giby V. George, et al.
Published: (2024-10-01)

Clonal hematopoiesis and inflammation: a link with thrombosis and malignancy
by: Tiziano Barbui
Published: (2022-07-01)

Clonal hematopoiesis of indeterminate potential and the risk of pulmonary embolism: an observational studyResearch in context
by: Qianwei Liu, et al.
Published: (2024-08-01)

Cellular heterogeneity and clonal hematopoiesis of immune system cells in atherosclerosis
by: A. A. Sleptsov
Published: (2022-11-01)

Clonal Hematopoiesis Is Associated With Long‐Term Adverse Outcomes Following Cardiac Surgery
by: Sandro Ninni, et al.
Published: (2024-09-01)

Molecular Pathways in Clonal Hematopoiesis: From the Acquisition of Somatic Mutations to Transformation into Hematologic Neoplasm
by: Charles Gaulin, et al.
Published: (2022-07-01)

Clonal Hematopoiesis of Indeterminate Potential From a Heart Failure Specialist's Point of View
by: Maurits A. Sikking, et al.
Published: (2023-08-01)

Chicken or Egg: Is Clonal Hematopoiesis Primarily Caused by Genetic or Epigenetic Aberrations?
by: Olivia Cypris, et al.
Published: (2019-09-01)

Low Impact of Clonal Hematopoiesis on the Determination of RAS Mutations by Cell-Free DNA Testing in Routine Clinical Diagnostics
by: Cristin Roma, et al.
Published: (2022-08-01)

Increased inflammatory signature in myeloid cells of non-small cell lung cancer patients with high clonal hematopoiesis burden
by: Hyungtai Sim, et al.
Published: (2024-12-01)

Association between clonal hematopoiesis-related gene mutations and unfavorable functional outcome in patients with large-artery atherosclerotic stroke
by: Xin Qiu, et al.
Published: (2023-12-01)

Birth Weight Is Associated With Clonal Hematopoiesis of Indeterminate Potential and Cardiovascular Outcomes in Adulthood
by: Art Schuermans, et al.
Published: (2023-07-01)

Book Review: The Human Immunodeficiency Virus: Biology, Immunology, and Therapy
by: James Whitney
Published: (2002-12-01)

Clinical Significance of Clonal Hematopoiesis of Indeterminate Potential in Hematology and Cardiovascular Disease
by: Gregor Hoermann
Published: (2022-07-01)

Genetic evidence for the causal effect of clonal hematopoiesis on pulmonary arterial hypertension
by: Jia-Yong Qiu, et al.
Published: (2025-01-01)

Obesity and Clonal Hematopoiesis of Indeterminate Potential: Allies in Cardiovascular Diseases and Malignancies
by: Luka Komic, et al.
Published: (2023-06-01)

Case Report: First longitudinal study of a patient with CALR positive clonal hematopoiesis of indeterminate potential developing into pre-fibrotic myelofibrosis
by: Lasse Kjær, et al.
Published: (2023-05-01)

Clonal hematopoiesis of indeterminate potential (CHIP) and cardiovascular diseases—an updated systematic review
by: Nagendra Boopathy Senguttuvan, et al.
Published: (2021-07-01)

Exploring the Impact of Clonal Hematopoiesis on Heart Failure and Remodeling in Aortic Stenosis
by: Minkwan Kim, MD, PhD
Published: (2025-02-01)

Experimental ASXL1‐Mediated Clonal Hematopoiesis Promotes Inflammation and Accelerates Heart Failure
by: Kyung‐Duk Min, et al.
Published: (2022-10-01)

Clinical significance of clonal hematopoiesis in the interpretation of blood liquid biopsy
by: Hiu Ting Chan, et al.
Published: (2020-08-01)

What Clonal Hematopoiesis Can Teach Us About MDS
by: Irenaeus C. C. Chan, et al.
Published: (2022-02-01)